Universal Health (UHS) | Financial Analysis & Statements
Universal Health Services Inc. Large-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
4.5B
Gross Profit
4.1B
90.58%
Operating Income
517.2M
11.53%
Net Income
447.8M
9.98%
EPS (Diluted)
$7.06
Balance Sheet Metrics
Total Assets
15.5B
Total Liabilities
8.1B
Shareholders Equity
7.4B
Debt to Equity
1.10
Cash Flow Metrics
Operating Cash Flow
596.4M
Free Cash Flow
287.5M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Universal Health Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 17.4B | 15.8B | 14.3B | 13.4B | 12.6B |
| Cost of Goods Sold | 1.7B | 1.6B | 1.5B | 1.5B | 1.4B |
| Gross Profit | 15.7B | 14.2B | 12.7B | 11.9B | 11.2B |
| Gross Margin % | 90.4% | 90.0% | 89.3% | 89.0% | 88.7% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 8.2B | 7.7B | 7.2B | 6.9B | 6.3B |
| Other Operating Expenses | 4.9B | 4.3B | 3.8B | 3.4B | 3.0B |
| Total Operating Expenses | 13.1B | 12.0B | 11.0B | 10.3B | 9.3B |
| Operating Income | 2.0B | 1.7B | 1.2B | 1.0B | 1.4B |
| Operating Margin % | 11.5% | 10.6% | 8.2% | 7.5% | 10.8% |
| Non-Operating Items | |||||
| Interest Income | 1.2M | 1.4M | 572.0K | 378.0K | 1.6M |
| Interest Expense | 152.3M | 182.5M | 202.2M | 122.4M | 83.7M |
| Other Non-Operating Income | 134.2M | 2.2M | -28.3M | -10.4M | 13.9M |
| Pre-tax Income | 2.0B | 1.5B | 940.4M | 866.3M | 1.3B |
| Income Tax | 461.0M | 334.8M | 221.1M | 209.3M | 305.7M |
| Effective Tax Rate % | 23.4% | 22.4% | 23.5% | 24.2% | 23.6% |
| Net Income | 1.5B | 1.2B | 719.3M | 657.0M | 987.6M |
| Net Margin % | 8.7% | 7.3% | 5.0% | 4.9% | 7.8% |
| Key Metrics | |||||
| EBITDA | 2.7B | 2.3B | 1.7B | 1.6B | 1.9B |
| EPS (Basic) | $23.42 | $17.16 | $10.35 | $9.23 | $11.99 |
| EPS (Diluted) | $23.10 | $16.82 | $10.23 | $9.14 | $11.82 |
| Basic Shares Outstanding | 63581000 | 66554000 | 69321000 | 73118000 | 82519000 |
| Diluted Shares Outstanding | 63581000 | 66554000 | 69321000 | 73118000 | 82519000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Universal Health Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 137.8M | 126.0M | 119.4M | 102.8M | 115.3M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 2.6B | 2.2B | 2.2B | 2.0B | 1.7B |
| Inventory | 232.1M | 220.9M | 217.0M | 218.5M | 206.8M |
| Other Current Assets | 435.6M | 291.6M | 236.7M | 198.3M | 194.8M |
| Total Current Assets | 3.4B | 2.8B | 2.8B | 2.5B | 2.3B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 3.8B | 3.7B | 3.5B | 3.4B | 3.1B |
| Goodwill | 8.0B | 7.9B | 7.9B | 7.8B | 7.9B |
| Intangible Assets | - | - | - | - | - |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 747.1M | 729.6M | 665.4M | 674.3M | 625.6M |
| Total Non-Current Assets | 12.1B | 11.7B | 11.2B | 11.0B | 10.8B |
| Total Assets | 15.5B | 14.5B | 14.0B | 13.5B | 13.1B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 750.1M | 632.0M | 614.0M | 636.6M | 658.9M |
| Short-term Debt | 821.4M | 114.7M | 198.3M | 149.2M | 112.9M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | - | - |
| Total Current Liabilities | 3.2B | 2.2B | 2.0B | 1.9B | 2.0B |
| Non-Current Liabilities | |||||
| Long-term Debt | 4.3B | 4.8B | 5.2B | 5.1B | 4.4B |
| Deferred Tax Liabilities | 5.6M | - | - | - | 0 |
| Other Non-Current Liabilities | 527.8M | 655.8M | 584.0M | 487.7M | 464.8M |
| Total Non-Current Liabilities | 4.9B | 5.5B | 5.8B | 5.6B | 4.9B |
| Total Liabilities | 8.1B | 7.7B | 7.8B | 7.5B | 6.9B |
| Equity | |||||
| Common Stock | 611.0K | 650.0K | 672.0K | 710.0K | 771.0K |
| Retained Earnings | 8.0B | 7.4B | 6.8B | 6.5B | 6.6B |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 7.4B | 6.8B | 6.2B | 6.0B | 6.2B |
| Key Metrics | |||||
| Total Debt | 5.2B | 5.0B | 5.4B | 5.3B | 4.6B |
| Working Capital | 168.3M | 605.9M | 798.0M | 622.9M | 279.4M |
Balance Sheet Composition
Universal Health Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 1.5B | 1.2B | 719.3M | 657.0M | 987.6M |
| Depreciation & Amortization | 618.7M | 584.8M | 568.0M | 581.9M | 533.2M |
| Stock-Based Compensation | 95.7M | 99.3M | 87.7M | 85.4M | 73.7M |
| Working Capital Changes | -227.7M | 138.9M | -124.1M | -391.4M | -782.5M |
| Operating Cash Flow | 1.7B | 1.8B | 1.1B | 790.8M | 720.5M |
| Investing Activities | |||||
| Capital Expenditures | -1.0B | -943.8M | -743.1M | -734.0M | -855.7M |
| Acquisitions | -47.7M | -18.7M | -3.7M | -20.2M | -105.3M |
| Investment Purchases | -62.0M | - | - | - | - |
| Investment Sales | 63.1M | - | - | - | - |
| Investing Cash Flow | -1.1B | -924.0M | -722.6M | -742.2M | -935.5M |
| Financing Activities | |||||
| Share Repurchases | -968.0M | -670.8M | -547.4M | -832.9M | -1.2B |
| Dividends Paid | -51.3M | -53.3M | -55.5M | -58.4M | -65.9M |
| Debt Issuance | 285.5M | 2.2B | 185.1M | 705.3M | 3.3B |
| Debt Repayment | -43.5M | -2.6B | -85.5M | -89.4M | -3.0B |
| Financing Cash Flow | -749.7M | -1.1B | -493.9M | -318.4M | -1.1B |
| Free Cash Flow | 824.6M | 1.1B | 524.7M | 262.0M | 28.0M |
| Net Change in Cash | -81.9M | -274.8M | -83.7M | -269.8M | -1.3B |
Cash Flow Trend
Universal Health Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
7.84
Forward P/E
7.08
Price to Book
1.52
Price to Sales
0.64
PEG Ratio
0.19
Profitability Ratios
Profit Margin
8.57%
Operating Margin
11.53%
Return on Equity
21.33%
Return on Assets
8.31%
Financial Health
Current Ratio
1.05
Debt to Equity
69.73
Beta
1.30
Per Share Data
EPS (TTM)
$23.10
Book Value per Share
$119.15
Revenue per Share
$273.11
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| UHS | 11.1B | 7.84 | 1.52 | 21.33% | 8.57% | 69.73 |
| HCA Healthcare | 106.0B | 16.86 | -38.44 | -244.82% | 8.97% | -17.57 |
| Tenet Healthcare | 16.5B | 12.17 | 3.88 | 27.02% | 6.60% | 160.79 |
| Ensign Group | 11.1B | 32.78 | 4.95 | 16.90% | 6.80% | 98.70 |
| Encompass Health | 10.2B | 18.52 | 4.21 | 24.82% | 9.54% | 82.85 |
| DaVita | 10.0B | 16.32 | 9.13 | 64.85% | 5.47% | 1,111.35 |
Financial data is updated regularly. All figures are in the company's reporting currency.






